Evidence map›Paper›PMID 27562754›Full record

ArticleIntegrative cancer therapies2017

Anti-inflammatory Effects of Phyllanthus emblica L on Benzopyrene-Induced Precancerous Lung Lesion by Regulating the IL-1β/miR-101/Lin28B Signaling Pathway.

Cheng-Cheng Wang, Jia-Rui Yuan, Chun-Fei Wang, Nan Yang, Juan Chen, Dan Liu, Jie Song, Liang Feng, Xiao-Bin Tan, Xiao-Bin Jia

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Mini reviews in medicinal chemistry · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Aqueous Extract ofIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  11. Review
  12. Aqueous Extract ofFoods (Basel, Switzerland) · 2022
    Article
  13. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Article
  14. Review
  15. Review
  16. Exploring the Mechanism through whichEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  17. Article
  18. Article
  19. MiR-502 Suppresses TNF-BioMed research international · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Cheng-Cheng Wang1 Nanjing University of Chinese Medicine, Jiangsu Nanjing, P R China.
Jia-Rui Yuan1 Nanjing University of Chinese Medicine, Jiangsu Nanjing, P R China.
Chun-Fei Wang2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Nan Yang1 Nanjing University of Chinese Medicine, Jiangsu Nanjing, P R China.
Juan Chen1 Nanjing University of Chinese Medicine, Jiangsu Nanjing, P R China.
Dan Liu2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Jie Song2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Liang Feng2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Xiao-Bin Tan2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Xiao-Bin Jia2 Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Nanjing, P R China.
Jiangsu Provincial Academy of Traditional Chinese Medicine · CNNanjing University of Chinese Medicine · CNAnhui University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhyllanthus emblica L (PEL), a well-known medical plant, has been used in Asian countries for a long time. Increasing evidence suggests that it can prevent the tumorigenesis of cancer associated with nonresolving inflammation. However, the possible anti-inflammatory mechanism responsible for preventing tumorigenesis of precancerous lung lesions is not well elucidated. MATERIALS AND

methodsMale A/J mice were randomly divided into 5 groups with 10 mice in each group: (1) blank group (saline), (2) benzo(a)pyrene [B(a)P] group, (3) and (4) B(a)P + PEL (5 g/kg/d, 10 g/kg/d, administered by gavage), (5) B(a)P + celecoxib (30 mg/kg/d, administered by gavage). Nodes on the lung surface were observed and calculated. The levels of macrophage inflammatory protein (MIP-2), tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β were detected by enzyme-linked immunosorbent assay (ELISA) kits. Cyclo-oxygenase-2 (COX-2), hypoxia-inducible factor-1 (HIF-α), IL-1β, miR-101, and Lin28B protein levels were evaluated by immunohistochemistry and Western blotting.

resultsPEL extract treatment significantly reduced the number of nodes on the lung surface and attenuated B(a)P-induced levels of proinflammatory cytokines MIP-2, TNF-α, IL-6, and IL-1β in lung tissue. The protein expressions of COX-2 and HIF-α were significantly decreased by the treatment of PEL. In addition, both PEL extract and celecoxib markedly upregulate the expression of miR-101 while downregulating IL-1β and Lin28B levels.

conclusionOur study indicated that treatment with PEL extract can not only protect the lung from inflammatory injury but effectively prevent precancerous lung lesions through regulating the IL-1β/miR-i101/Lin28B signaling pathway.

Indexed as

AnimalsAnti-Inflammatory AgentsBenzopyrenesCyclooxygenase 2CytokinesDNA-Binding ProteinsDown-RegulationInflammationInterleukin-1betaInterleukin-6LungMaleMiceMicroRNAsNF-kappa BPhyllanthus emblicaAnti-Inflammatory AgentsBenzopyrenesCyclooxygenase 2CytokinesDNA-Binding ProteinsInterleukin-1betaInterleukin-6Lin28b protein, mouseMicroRNAsMIRN101 microRNA, mouseNF-kappa BPlant ExtractsRNA-Binding ProteinsTumor Necrosis Factor-alphaanti-inflammatoryIL-1β/miR-101/Lin28B signaling pathwayPhyllanthus emblica Lprecancerous lung lesion

Identifiers

PMID27562754
PMCPMC5739133
OpenAlexW2515466661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.